1
|
McGlumphy S, Damai A, Salameh L, Corbin GB, Wang Q, Markiewicz J, Mosher JJ, Spitzer N, Quiñones R. Biocompatible antibiotic-coupled nickel-titanium nanoparticles as a potential coating material for biomedical devices. Heliyon 2024; 10:e31434. [PMID: 38831845 PMCID: PMC11145499 DOI: 10.1016/j.heliyon.2024.e31434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2024] [Revised: 05/04/2024] [Accepted: 05/15/2024] [Indexed: 06/05/2024] Open
Abstract
The challenges facing metallic implants for reconstructive surgery include the leaching of toxic metal ions, a mismatch in elastic modulus between the implant and the treated tissue, and the risk of infection. These problems can be addressed by passivating the metal surface with an organic substrate and incorporating antibiotic molecules. Nitinol (NiTi), a nickel-titanium alloy, is used in devices for biomedical applications due to its shape memory and superelasticity. However, unmodified NiTi carries a risk of localized nickel toxicity and inadequately supports angiogenesis or neuroregeneration due to limited cell adhesion, poor biomineralization, and little antibacterial activity. To address these challenges, NiTi nanoparticles were modified using self-assembled phosphonic acid monolayers and functionalized with the antibiotics ceftriaxone and vancomycin via the formation of an amide. Surface modifications were monitored to confirm that phosphonic acid modifications were present on NiTi nanoparticles and 100% of the samples formed ordered films. Modifications were stable for more than a year. Elemental composition showed the presence of nickel, titanium, and phosphorus (1.9% for each sample) after surface modifications. Dynamic light scattering analysis suggested some agglomeration in solution. However, scanning electron microscopy coupled with energy-dispersive X-ray spectroscopy confirmed a particle size distribution of <100 nm, the even distribution of nanoparticles on coverslips, and elemental composition before and after cell culture. B35 neuroblastoma cells exhibited no inhibition of survival and extended neurites of approximately 100 μm in total length when cultured on coverslips coated with only poly-l-lysine or with phosphonic acid-modified NiTi, indicating high biocompatibility. The ability to support neural cell growth and differentiation makes modified NiTi nanoparticles a promising coating for surfaces in metallic bone and nerve implants. NiTi nanoparticles functionalized with ceftriaxone inhibited Escherichia coli and Serratia marcescens (SM6) at doses of 375 and 750 μg whereas the growth of Bacillus subtilis was inhibited by a dose of only 37.5 μg. NiTi-vancomycin was effective against B. subtilis at all doses even after mammalian cell culture. These are common bacteria associated with infected implants, further supporting the potential use of functionalized NiTi in coating reconstructive implants.
Collapse
Affiliation(s)
- Sarah McGlumphy
- Department of Chemistry, Marshall University, Huntington, WV, 25755, USA
- Department of Biological Sciences, Marshall University, Huntington, WV, 25755, USA
| | - Aakriti Damai
- Department of Chemistry, Marshall University, Huntington, WV, 25755, USA
- Department of Biological Sciences, Marshall University, Huntington, WV, 25755, USA
| | - Lena Salameh
- Department of Chemistry, Marshall University, Huntington, WV, 25755, USA
| | - Gabriell B. Corbin
- Department of Biological Sciences, Marshall University, Huntington, WV, 25755, USA
| | - Qiang Wang
- Shared Research Facilities, West Virginia University, Morgantown, WV, 25606, USA
| | - John Markiewicz
- Department of Chemistry, Marshall University, Huntington, WV, 25755, USA
| | - Jennifer J. Mosher
- Department of Biological Sciences, Marshall University, Huntington, WV, 25755, USA
| | - Nadja Spitzer
- Department of Biological Sciences, Marshall University, Huntington, WV, 25755, USA
| | - Rosalynn Quiñones
- Department of Chemistry, Marshall University, Huntington, WV, 25755, USA
| |
Collapse
|
2
|
Eve DJ, Sanberg PR, Buzanska L, Sarnowska A, Domanska-Janik K. Human Somatic Stem Cell Neural Differentiation Potential. Results Probl Cell Differ 2018; 66:21-87. [DOI: 10.1007/978-3-319-93485-3_2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/09/2023]
|
3
|
Hall VJ. Early development of the porcine embryo: the importance of cell signalling in development of pluripotent cell lines. Reprod Fertil Dev 2013; 25:94-102. [PMID: 23244832 DOI: 10.1071/rd12264] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Understanding the cell signalling events that govern cell renewal in porcine pluripotent cells may help improve culture conditions and allow for establishment of bona fide porcine embryonic stem cells (pESC) and stable porcine induced pluripotent stem cells (piPSC). This review investigates cell signalling in the porcine preimplantation embryo containing either the inner cell mass or epiblast, with particular emphasis on fibroblast growth factor, SMAD, WNT and Janus tyrosine kinases/signal transducers and activators of transcription signalling. It is clear that key differences exist in the cell signalling events that govern pluripotency in this species compared with similar embryonic stages in mouse and human. The fact that bona fide pESC have still not been produced and that piPSC cannot survive in culture following the silencing or downregulation of the reprogramming transgenes suggest that culture conditions are not optimal. Unravelling the factor/s that regulate pluripotency in porcine embryos will pave the way for future establishment of stable pluripotent stem cell lines.
Collapse
Affiliation(s)
- Vanessa Jane Hall
- University of Copenhagen, Faculty of Health and Medical Sciences, Department of Veterinary Clinical and Animal Sciences, Gronnegaardsvej 7, DK-1870 Frederiksberg C, Denmark.
| |
Collapse
|